iKnowMed Named Top Performing Electronic Health Record (EHR) System for Oncology and Hematology Practices for the Second Year in

  iKnowMed Named Top Performing Electronic Health Record (EHR) System for
  Oncology and Hematology Practices for the Second Year in a Row

 McKesson Specialty Health EHR iKnowMed recognized for strong performance by
two independent, industry-leading research firms: Black Book Rankings and KLAS

Business Wire

THE WOODLANDS, Texas -- January 22, 2013

For the second consecutive year, iKnowMed electronic health record (EHR) has
been named the top ranked EHR for oncologists and hematologists by Black Book
Rankings, a division of the Brown-Wilson Group, an unbiased source for
polling, surveys and market research. In addition, KLAS, an independently
owned and operated healthcare industry research firm, recently indicated that
iKnowMed attained the highest medical oncology-specific performance rating for
an EHR built for the ambulatory setting.

“Created in close collaboration with the physicians of The US Oncology
Network, the broad functionality of iKnowMed delivers multiple benefits for
community oncology practices - including enhanced patient safety, work flow
efficiency and evidence-based clinical decision support at the point of care,”
said Asif Ahmad, SVP of Technology for McKesson Specialty Health. “We are
excited to see the undeniable value of iKnowMed reflected in these important
industry benchmarks.”

Black Book annual rankings are compiled based on feedback from EHR users
across 18 performance criteria, including overall performance, innovation,
training and customer support. iKnowMed was recognized for its superior focus
on meeting the unique needs of community-based oncology practices.

More than 380,000 practice management and physician leaders, and other users
including IT specialists and front-line implementation veterans were invited
to participate in the 2012 annual Black Book Rankings survey. iKnowMed
received “overwhelming satisfaction” rankings in all 18 key performance areas
among the EHRs in the ambulatory oncology/hematology category.

In addition to the high rating in Black Book Rankings, iKnowMed also attained
a high rating in the 2012 KLAS report, “Oncology 2012: Pulling the Curtain
Back.” This comprehensive report features in-depth analysis of leading
Oncology IT systems based on provider opinions obtained over the last year.
iKnowMed was rated as superior to other medical oncology-specific EHRs in
multiple areas including cancer staging, cancer-specific templates, and dose
calculating.

“iKnowMed continues to make advancements,” says Scott Kruger, MD, medical
oncologist with Virginia Oncology Associates, a member of The US Oncology
Network. “There have been many hurdles with the changing technology and
requirements for Meaningful Use. We can tell the technology team is listening
to our needs and incorporating our feedback into iKnowMed development plans.
In the last year we have seen increased speed, reduction in clicks required to
perform tasks and improvements in overall ease of use. The new medical record
system in development, iKnowMed Generation 2, will incorporate these and other
enhancements to help make iKnowMed an ongoing leader in the future of
community oncology care. “

Currently, iKnowMed is implemented in more than 400 sites of care nationwide
by more than 1,300 providers and is fully integrated with its patient portal,
My Care Plus, which provides more than 20,000 enrolled patients secure, online
access to their health records. The web-based EHR allows practices to have
24/7 immediate access to comprehensive patient charts, detailed cancer
diagnosis and staging content, and an extensive up-to-date cancer regimen
library that enables them to contemplate different treatment options from
anywhere at any time without the need of a patient’s paper record. iKnowMed
EHR further enhances patient safety in the practice through the elimination of
handwritten notes and drug orders, which minimizes misinterpretations, and
through safety alerts generated through the system when it detects possible
medication conflicts or high toxicity levels. The system also has the ability
to identify patients for appropriate clinical trials available at the practice
and suggests evidence-based treatment options with point-of-care decision
support.

For more information about Black Book Rankings and the KLAS report or to
request a demonstration of iKnowMed, visit
http://www.mckesson.com/iKnowMed2013.

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, empowers the
community patient care delivery system by helping community practices advance
the science, technology and quality of care. Through innovative clinical,
research, business and operational solutions, facilitated by integrated
technology systems, we focus on improving the financial health of our
customers so they may provide the best care to their patients. For more
information, visit www.mckessonspecialtyhealth.com.

About The US Oncology Network

The US Oncology Network is one of the nation’s largest networks of
community-based oncology physicians dedicated to advancing cancer care in
America. Like-minded physicians are united through The Network around a common
vision of expanding patient access to high-quality, integrated cancer care in
communities throughout the nation. Leveraging healthcare information
technology, shared best practices, refined evidence-based medicine guidelines,
and quality measurements, physicians affiliated with The US Oncology Network
are committed to advancing the quality, safety, and science of cancer care to
improve patient outcomes. The US Oncology Network is supported by McKesson
Specialty Health, a division of McKesson Corporation focused on empowering a
vibrant and sustainable community patient care delivery system. For more
information, visit www.usoncology.com.

Contact:

McKesson Specialty Health
Claire Crye, 281-863-6783
claire.crye@mckesson.com
 
Press spacebar to pause and continue. Press esc to stop.